Andrew Hill Investment Advisors adds GS, TMO, PG, DE exits COST among Q4 moves
Seeking Alpha News (Thu, 8-Jan 7:41 AM ET)
Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference
Business Wire (Tue, 6-Jan 8:00 AM ET)
Federal appeals court rejects NIH research funding cuts
Seeking Alpha News (Tue, 6-Jan 7:16 AM ET)
Citi Reaffirms Their Buy Rating on Thermo Fisher (TMO)
TipRanks (Mon, 5-Jan 9:45 AM ET)
Seeking Alpha News (Sun, 4-Jan 9:05 AM ET)
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 29, 2026
Business Wire (Fri, 26-Dec 8:00 AM ET)
Business Wire (Mon, 15-Dec 10:11 AM ET)
Business Wire (Tue, 2-Dec 5:00 PM ET)
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
Business Wire (Mon, 24-Nov 9:10 PM ET)
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
Business Wire (Thu, 20-Nov 4:15 PM ET)
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Thermo Fisher Scientific trades on the NYSE stock market under the symbol TMO.
As of January 8, 2026, TMO stock price declined to $606.50 with 2,884,881 million shares trading.
TMO has a beta of 0.80, meaning it tends to be less sensitive to market movements. TMO has a correlation of 0.19 to the broad based SPY ETF.
TMO has a market cap of $228.81 billion. This is considered a Mega Cap stock.
Last quarter Thermo Fisher Scientific reported $11 billion in Revenue and $5.79 earnings per share. This beat revenue expectation by $209 million and exceeded earnings estimates by $.29.
In the last 3 years, TMO traded as high as $628.08 and as low as $385.46.
The top ETF exchange traded funds that TMO belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
TMO has underperformed the market in the last year with a return of +11.5%, while SPY returned +18.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in TMO shares. However, TMO has outperformed the market in the last 3 month and 2 week periods, returning +12.6% and +4.7%, while SPY returned +3.3% and -0.1%, respectively. This indicates TMO has been having a stronger performance recently.
TMO support price is $608.89 and resistance is $625.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TMO shares will trade within this expected range on the day.